Cubist Systematic Strategies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Cubist Systematic Strategies’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,931	Closed	-$353K	–	4742
2022 Q1	$353K	Sell	18,931 -44,356	-70%	-$798K	﹤0.01%	2746
2021 Q4	$1.35M	Buy	63,287 +41,133	+186%	+$810K	0.01%	1679
2021 Q3	$409K	Buy	22,154 +10,309	+87%	+$208K	0.01%	2163
2021 Q2	$254K	Sell	11,845 -72,955	-86%	-$1.48M	﹤0.01%	2428
2021 Q1	$1.64M	Buy	+84,800	New	+$1.49M	0.02%	1183

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cubist Systematic Strategies's OCDX Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 18,931 shares — an estimated $353K sold.

Cubist Systematic Strategies first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $1.64M in Q1 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Cubist Systematic Strategies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 18,931 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $353K.
Cubist Systematic Strategies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Cubist Systematic Strategies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.64M in Q1 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.